Cargando…

Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study

In this study, hybrid analogs of benzimidazole containing a thiazole moiety (1–17) were afforded and then tested for their ability to inhibit α-amylase and α-glucosidase when compared to acarbose as a standard drug. The recently available analogs showed a wide variety of inhibitory potentials that r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Rafaqat, Iqbal, Shahid, Shah, Mazloom, Rehman, Wajid, Khan, Shoaib, Rasheed, Liaqat, Rahim, Fazal, Dera, Ayed A., Kehili, Sana, Elkaeed, Eslam B., Awwad, Nasser S., Bajaber, Majed A., Alahmdi, Mohammed Issa, Alrbyawi, Hamad, Alsaab, Hashem O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572811/
https://www.ncbi.nlm.nih.gov/pubmed/36234994
http://dx.doi.org/10.3390/molecules27196457
_version_ 1784810709822996480
author Hussain, Rafaqat
Iqbal, Shahid
Shah, Mazloom
Rehman, Wajid
Khan, Shoaib
Rasheed, Liaqat
Rahim, Fazal
Dera, Ayed A.
Kehili, Sana
Elkaeed, Eslam B.
Awwad, Nasser S.
Bajaber, Majed A.
Alahmdi, Mohammed Issa
Alrbyawi, Hamad
Alsaab, Hashem O.
author_facet Hussain, Rafaqat
Iqbal, Shahid
Shah, Mazloom
Rehman, Wajid
Khan, Shoaib
Rasheed, Liaqat
Rahim, Fazal
Dera, Ayed A.
Kehili, Sana
Elkaeed, Eslam B.
Awwad, Nasser S.
Bajaber, Majed A.
Alahmdi, Mohammed Issa
Alrbyawi, Hamad
Alsaab, Hashem O.
author_sort Hussain, Rafaqat
collection PubMed
description In this study, hybrid analogs of benzimidazole containing a thiazole moiety (1–17) were afforded and then tested for their ability to inhibit α-amylase and α-glucosidase when compared to acarbose as a standard drug. The recently available analogs showed a wide variety of inhibitory potentials that ranged between 1.31 ± 0.05 and 38.60 ± 0.70 µM (against α-amylase) and between 2.71 ± 0.10 and 42.31 ± 0.70 µM (against α-glucosidase) under the positive control of acarbose (IC(50) = 10.30 ± 0.20 µM against α-amylase) (IC(50) = 9.80 ± 0.20 µM against α-glucosidase). A structure–activity relationship (SAR) study was carried out for all analogs based on substitution patterns around both rings B and C respectively. It was concluded from the SAR study that analogs bearing either substituent(s) of smaller size (−F and Cl) or substituent(s) capable of forming hydrogen bonding (−OH) with the catalytic residues of targeted enzymes enhanced the inhibitory potentials. Therefore, analogs 2 (bearing meta-fluoro substitution), 3 (having para-fluoro substitution) and 4 (with ortho-fluoro group) showed enhanced potency when evaluated against standard acarbose drug with IC(50) values of 4.10 ± 0.10, 1.30 ± 0.05 and 1.90 ± 0.10 (against α-amylase) and 5.60 ± 0.10, 2.70 ± 0.10 and 2.90 ± 0.10 µM (against α-glucosidase), correspondingly. On the other hand, analogs bearing substituent(s) of either a bulky nature (−Br) or that are incapable of forming hydrogen bonds (−CH(3)) were found to lower the inhibitory potentials. In order to investigate the binding sites for synthetic analogs and how they interact with the active areas of both targeted enzymes, molecular docking studies were also conducted on the potent analogs. The results showed that these analogs adopted many important interactions with the active areas of enzymes. The precise structure of the newly synthesized compounds was confirmed using several spectroscopic techniques as NMR and HREI-MS.
format Online
Article
Text
id pubmed-9572811
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95728112022-10-17 Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study Hussain, Rafaqat Iqbal, Shahid Shah, Mazloom Rehman, Wajid Khan, Shoaib Rasheed, Liaqat Rahim, Fazal Dera, Ayed A. Kehili, Sana Elkaeed, Eslam B. Awwad, Nasser S. Bajaber, Majed A. Alahmdi, Mohammed Issa Alrbyawi, Hamad Alsaab, Hashem O. Molecules Article In this study, hybrid analogs of benzimidazole containing a thiazole moiety (1–17) were afforded and then tested for their ability to inhibit α-amylase and α-glucosidase when compared to acarbose as a standard drug. The recently available analogs showed a wide variety of inhibitory potentials that ranged between 1.31 ± 0.05 and 38.60 ± 0.70 µM (against α-amylase) and between 2.71 ± 0.10 and 42.31 ± 0.70 µM (against α-glucosidase) under the positive control of acarbose (IC(50) = 10.30 ± 0.20 µM against α-amylase) (IC(50) = 9.80 ± 0.20 µM against α-glucosidase). A structure–activity relationship (SAR) study was carried out for all analogs based on substitution patterns around both rings B and C respectively. It was concluded from the SAR study that analogs bearing either substituent(s) of smaller size (−F and Cl) or substituent(s) capable of forming hydrogen bonding (−OH) with the catalytic residues of targeted enzymes enhanced the inhibitory potentials. Therefore, analogs 2 (bearing meta-fluoro substitution), 3 (having para-fluoro substitution) and 4 (with ortho-fluoro group) showed enhanced potency when evaluated against standard acarbose drug with IC(50) values of 4.10 ± 0.10, 1.30 ± 0.05 and 1.90 ± 0.10 (against α-amylase) and 5.60 ± 0.10, 2.70 ± 0.10 and 2.90 ± 0.10 µM (against α-glucosidase), correspondingly. On the other hand, analogs bearing substituent(s) of either a bulky nature (−Br) or that are incapable of forming hydrogen bonds (−CH(3)) were found to lower the inhibitory potentials. In order to investigate the binding sites for synthetic analogs and how they interact with the active areas of both targeted enzymes, molecular docking studies were also conducted on the potent analogs. The results showed that these analogs adopted many important interactions with the active areas of enzymes. The precise structure of the newly synthesized compounds was confirmed using several spectroscopic techniques as NMR and HREI-MS. MDPI 2022-09-30 /pmc/articles/PMC9572811/ /pubmed/36234994 http://dx.doi.org/10.3390/molecules27196457 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hussain, Rafaqat
Iqbal, Shahid
Shah, Mazloom
Rehman, Wajid
Khan, Shoaib
Rasheed, Liaqat
Rahim, Fazal
Dera, Ayed A.
Kehili, Sana
Elkaeed, Eslam B.
Awwad, Nasser S.
Bajaber, Majed A.
Alahmdi, Mohammed Issa
Alrbyawi, Hamad
Alsaab, Hashem O.
Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study
title Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study
title_full Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study
title_fullStr Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study
title_full_unstemmed Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study
title_short Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study
title_sort synthesis of novel benzimidazole-based thiazole derivatives as multipotent inhibitors of α-amylase and α-glucosidase: in vitro evaluation along with molecular docking study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572811/
https://www.ncbi.nlm.nih.gov/pubmed/36234994
http://dx.doi.org/10.3390/molecules27196457
work_keys_str_mv AT hussainrafaqat synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT iqbalshahid synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT shahmazloom synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT rehmanwajid synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT khanshoaib synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT rasheedliaqat synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT rahimfazal synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT deraayeda synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT kehilisana synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT elkaeedeslamb synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT awwadnassers synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT bajabermajeda synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT alahmdimohammedissa synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT alrbyawihamad synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy
AT alsaabhashemo synthesisofnovelbenzimidazolebasedthiazolederivativesasmultipotentinhibitorsofaamylaseandaglucosidaseinvitroevaluationalongwithmoleculardockingstudy